SE7413833L - - Google Patents

Info

Publication number
SE7413833L
SE7413833L SE7413833A SE7413833A SE7413833L SE 7413833 L SE7413833 L SE 7413833L SE 7413833 A SE7413833 A SE 7413833A SE 7413833 A SE7413833 A SE 7413833A SE 7413833 L SE7413833 L SE 7413833L
Authority
SE
Sweden
Application number
SE7413833A
Other versions
SE415762B (sv
Inventor
R A Archer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7413833L publication Critical patent/SE7413833L/xx
Publication of SE415762B publication Critical patent/SE415762B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
SE7413833A 1973-11-05 1974-11-04 Forfarande for framstellnig av terapeutiskt verksamma hexahysrodibenso(b,d)-pyraner med hydroxi-och/eller alkanoyloxi-substituenter i 1-och 9-stellningarna SE415762B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/413,010 US3968125A (en) 1973-11-05 1973-11-05 Dihydroxyhexahydrodibenzo[b,d]pyrans

Publications (2)

Publication Number Publication Date
SE7413833L true SE7413833L (fr) 1975-05-06
SE415762B SE415762B (sv) 1980-10-27

Family

ID=23635420

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7413833A SE415762B (sv) 1973-11-05 1974-11-04 Forfarande for framstellnig av terapeutiskt verksamma hexahysrodibenso(b,d)-pyraner med hydroxi-och/eller alkanoyloxi-substituenter i 1-och 9-stellningarna

Country Status (26)

Country Link
US (1) US3968125A (fr)
JP (1) JPS6033835B2 (fr)
AR (1) AR202318A1 (fr)
AT (1) AT336012B (fr)
BE (1) BE821716A (fr)
BG (1) BG26387A3 (fr)
CA (1) CA1023753A (fr)
CH (1) CH605894A5 (fr)
CS (1) CS193507B2 (fr)
DD (1) DD116230A5 (fr)
DE (1) DE2451934C2 (fr)
DK (1) DK136719B (fr)
ES (1) ES431674A1 (fr)
FR (1) FR2249664B1 (fr)
GB (1) GB1487637A (fr)
HU (1) HU169193B (fr)
IE (1) IE40023B1 (fr)
IL (1) IL45644A (fr)
NL (1) NL7414439A (fr)
PH (1) PH11788A (fr)
PL (2) PL95748B1 (fr)
RO (1) RO71766A (fr)
SE (1) SE415762B (fr)
SU (1) SU524517A3 (fr)
YU (1) YU36515B (fr)
ZA (1) ZA745751B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
US4454144A (en) * 1982-06-21 1984-06-12 Pfizer Inc. Substituted dibenzo[b,d]pyran analgesics
JPS6299930U (fr) * 1985-12-12 1987-06-25
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP2130820A1 (fr) 2002-02-19 2009-12-09 Shionogi & Co., Ltd. Antiprurigineux
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
ES2534900T3 (es) * 2007-07-30 2015-04-30 Zynerba Pharmaceuticals, Inc. Profármacos de cannabidiol, composiciones que comprenden los profármacos de cannabidiol y métodos de uso de los mismos
US8829043B2 (en) 2008-02-08 2014-09-09 Nektar Therapeutics Oligome-cannabinoid conjugates
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
EP2398500B1 (fr) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Sustème d'administration de médicament à base de glutathionne
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2019016814A1 (fr) 2017-07-20 2019-01-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions de film pharmaceutique pour l'administration de composés lipophiles dans et/ou à travers la peau
CN111278425B (zh) 2017-09-11 2024-06-11 耶路撒冷希伯来大学伊萨姆研究开发有限公司 用于向脑部经鼻给药药物和用于全身作用的组合物和方法
US20200345656A1 (en) 2017-11-29 2020-11-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cannabinoids compositions and methods
EP3873436A1 (fr) 2018-11-04 2021-09-08 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Compositions contenant des cannabinoïdes administrables par voie orale et procédés

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
CH558792A (de) * 1971-10-14 1975-02-14 Petrzilka Theodor Verfahren zur herstellung von tetrahydrodibenzopyranen.

Also Published As

Publication number Publication date
IL45644A0 (en) 1974-11-29
AR202318A1 (es) 1975-05-30
SU524517A3 (ru) 1976-08-05
ZA745751B (en) 1976-04-28
HU169193B (fr) 1976-10-28
DE2451934A1 (de) 1975-05-07
IE40023L (en) 1975-05-05
DK136719C (fr) 1978-04-24
AT336012B (de) 1977-04-12
YU36515B (en) 1984-02-29
CH605894A5 (fr) 1978-10-13
IL45644A (en) 1978-03-10
US3968125A (en) 1976-07-06
ATA886374A (de) 1976-08-15
CA1023753A (fr) 1978-01-03
YU265874A (en) 1982-02-25
SE415762B (sv) 1980-10-27
JPS6033835B2 (ja) 1985-08-05
DD116230A5 (fr) 1975-11-12
BG26387A3 (bg) 1979-03-15
AU7321274A (en) 1976-03-18
DE2451934C2 (de) 1983-10-06
ES431674A1 (es) 1976-11-16
DK136719B (da) 1977-11-14
CS193507B2 (en) 1979-10-31
NL7414439A (nl) 1975-05-07
BE821716A (fr) 1975-04-30
DK573274A (fr) 1975-07-07
GB1487637A (en) 1977-10-05
JPS5071678A (fr) 1975-06-13
PL93908B1 (fr) 1977-07-30
FR2249664B1 (fr) 1978-03-24
FR2249664A1 (fr) 1975-05-30
PL95748B1 (pl) 1977-11-30
RO71766A (fr) 1982-12-06
IE40023B1 (en) 1979-02-28
PH11788A (en) 1978-07-05

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU465372B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474593B2 (fr)
DK136719C (fr)
AU465453B2 (fr)
AU465434B2 (fr)
AU450229B2 (fr)
AU476714B2 (fr)
AR201229Q (fr)
AR199451A1 (fr)
AU476696B2 (fr)
AU472848B2 (fr)
AU466283B2 (fr)
AR200885A1 (fr)
AU477824B2 (fr)
AR210729A1 (fr)
AR195948A1 (fr)
AU476873B1 (fr)
AR196382A1 (fr)
AR197627A1 (fr)
AR200256A1 (fr)
AR196212Q (fr)
AU1891376A (fr)